Keywords: axovan, gets, major, funding, boost, switzerland-based, biotechnology
Axovan gets major funding boost
Article | 29 April 2002
Switzerland-based biotechnology company Axovan AG says that it hassecured 30 million Swiss francs ($17.9 million) in a second round of financing led ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
